The recent findings of a huge study may erase some concerns about a pain reliever that has long been saddled with a worrisome reputation: celecoxib (Celebrex). While all nonsteroidal anti-inflammatory ...

Objectives We hypothesised that celecoxib, a COX-2 specific inhibitor, would be as effective as conventional NSAIDs and better than placebo in the treatment of ankle sprain. Methods Two separate ...

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery ...

In addition, although not a prespecified endpoint, rofecoxib resulted in significantly greater improvement than celecoxib in scores for each of the WOMAC composite domains (pain, stiffness, and ...

We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty. Methods: This was a prospective, randomized, observer-blind ...

The analysis showed that patients with positive blood tests for circulating tumor DNA (ctDNA) had worse outcomes in general, but those who were treated with celecoxib, a non-steroidal anti ...